Compounding Pharmacy

Compounding Pharmacy

Global Compounding Pharmacy Market to Reach US$19.7 Billion by 2030

The global market for Compounding Pharmacy estimated at US$14.5 Billion in the year 2023, is expected to reach US$19.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Oral Compounded Medications, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Topical Compounded Medications segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 4.2% CAGR

The Compounding Pharmacy market in the U.S. is estimated at US$3.9 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Compounding Pharmacy Market - Key Trends and Drivers Summarized

How Are Compounding Pharmacies Tailoring Personalized Medicine for Modern Healthcare?

Compounding pharmacies play a critical role in modern healthcare by providing customized medications tailored to the specific needs of individual patients. Unlike mass-produced pharmaceuticals, compounded medications are created by pharmacists who mix ingredients to form personalized treatments, adjusting dosage forms, strengths, or ingredients based on a patient’s unique requirements. This is particularly important for patients who cannot take commercially available medications due to allergies, difficulty swallowing pills, or specific dosage needs that are not available in mass-produced drugs. Compounded medications are used across a wide range of medical fields, including dermatology, pediatrics, pain management, and hormone replacement therapy. In recent years, the demand for personalized medicine has increased, as patients and healthcare providers seek more precise treatments that cater to individual health conditions. This shift highlights the growing importance of compounding pharmacies in filling the gaps left by standard pharmaceutical manufacturing, offering a personalized approach to medicine that enhances patient care and outcomes.

How Are Technological Advances Revolutionizing Compounding Pharmacy Practices?

The practice of compounding pharmacy has seen significant advancements, driven by cutting-edge technologies that have made the preparation of customized medications more efficient, accurate, and safe. Automation has been one of the most transformative developments, with automated compounding systems allowing for precise measurements of active ingredients, reducing human error, and increasing the speed of production. This is especially crucial in the preparation of sterile compounds, where any contamination can pose significant risks. Furthermore, advancements in pharmaceutical software have enabled compounding pharmacists to streamline their workflows, ensuring more accurate record-keeping, better inventory management, and compliance with regulatory standards. Digital platforms now allow pharmacists to cross-reference drug interactions and patient allergies quickly, further enhancing the safety and efficacy of compounded medications. The use of advanced compounding techniques, such as transdermal gels, rapid-dissolve tablets, and sustained-release formulations, has expanded the range of treatments available to patients, offering more flexible and innovative ways to deliver medications. Additionally, the rise of 3D printing technology in pharmaceuticals is beginning to influence compounding practices, with the potential to print personalized medications in precise dosages and forms, further pushing the boundaries of what can be achieved in tailored treatments. These technological innovations are improving the quality and accessibility of compounded medications, making personalized treatments more scalable and reliable.

How Is Compounding Pharmacy Serving Diverse Healthcare Needs Across Various Fields?

Compounding pharmacies cater to a diverse range of healthcare needs, providing solutions in areas where traditional pharmaceutical products may fall short. In pediatrics, for instance, compounded medications offer tailored dosages that are often unavailable in mass-market drugs, and pharmacists can prepare formulations in liquid, flavored, or chewable forms to make them more palatable for children. In dermatology, compounding pharmacies produce customized creams, ointments, and gels that address specific skin conditions such as psoriasis, eczema, and acne, often blending multiple active ingredients to create a comprehensive treatment in a single product. Pain management is another field where compounding pharmacies are vital, especially for patients with chronic pain who require precise formulations of medications such as opioids, muscle relaxants, or anti-inflammatories in customized doses or delivery methods, such as topical creams or transdermal patches, to minimize systemic side effects. Hormone replacement therapy (HRT) is another area where compounding pharmacies excel, creating individualized doses of bioidentical hormones tailored to the hormonal needs of patients undergoing menopause or other endocrine imbalances. Furthermore, compounding pharmacies are often relied upon in veterinary medicine, where medications for animals must be tailored in terms of dosage and formulation, sometimes flavored to ensure compliance. Across these various fields, compounding pharmacies offer personalized solutions that meet the specific needs of patients who might otherwise struggle to find appropriate treatments through conventional pharmaceuticals.

What Are the Factors Behind the Growth of the Compounding Pharmacy Market?

The growth in the compounding pharmacy market is driven by several factors, reflecting both the evolving needs of healthcare and advancements in pharmaceutical practices. One of the key drivers is the increasing demand for personalized medicine, as patients and healthcare providers seek more individualized treatments tailored to specific conditions, allergies, and preferences. This trend is particularly strong in fields like hormone replacement therapy (HRT), pain management, and pediatric care, where standard dosages and formulations often do not meet patient needs. Another significant factor is the shortage or discontinuation of certain medications from large pharmaceutical manufacturers, which has led healthcare providers to turn to compounding pharmacies to fill the gaps and ensure continued treatment for their patients. Additionally, regulatory changes and concerns about the safety and effectiveness of mass-produced medications, particularly with recalls or drug shortages, have spurred greater reliance on compounding pharmacies to provide alternative solutions. Technological advancements, such as the introduction of automation in compounding processes and enhanced digital tools for managing patient data, are also driving market growth by increasing the efficiency and accuracy of compounded drug production. Furthermore, the rise in healthcare costs and the growing number of aging populations in developed regions are pushing demand for more tailored and affordable treatment options, which compounding pharmacies are uniquely positioned to provide. Lastly, the increasing awareness of compounding’s role in veterinary medicine, offering solutions that are often not available in the traditional pharmaceutical market, is expanding the scope of the compounding pharmacy market. Together, these factors are contributing to the sustained growth of compounding pharmacies as a critical element of personalized healthcare solutions.

Select Competitors (Total 27 Featured) -

• B. Braun Melsungen AG
• Dougherty's Pharmacy, Inc.
• Fagron NV
• Fresenius Kabi AG
• Village Compounding Pharmacy
• Wedgewood Pharmacy

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.